Crossmark

Advantages of continuous subcutaneous insulin infusion vs. multiple daily injections for the treatment of subjects with type 1 diabetes: Are there still doubts?

Crossref DOI link: https://doi.org/10.1016/j.medcle.2016.05.003

Published Print: 2016-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chico, Ana
License Information

Text and Data Mining valid from 2016-03-01
More Information

This article is maintained by: Elsevier

Article Title: Advantages of continuous subcutaneous insulin infusion vs. multiple daily injections for the treatment of subjects with type 1 diabetes: Are there still doubts?

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2016.05.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2016.01.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcle.2015.09.006

Content Type: article

Copyright: © 2016 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below